Get started
Cingulate Inc.Cingulate Inc.Cingulate Inc.

Cingulate Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CING chart


Full chart

CING upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.71 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−16.32 USD
Net income (FY)
‪−15.55 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪3.81 M‬
Beta (1Y)
8.96

Employees


Employees (FY)
13
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.20 M‬ USD

About Cingulate Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Shane J. Schaffer
Website
cingulate.com
Headquarters
Kansas City
Founded
2012
FIGI
BBG012G40MY2
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CING news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CING.

Frequently Asked Questions


The current price of CING is 4.24 USD — it has increased by 1.44% in the past 24 hours. Watch Cingulate Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cingulate Inc. stocks are traded under the ticker CING.
CING stock has risen by 15.22% compared to the previous week, the month change is a 15.22% rise, over the last year Cingulate Inc. has showed a −58.91% decrease.
We've gathered analysts' opinions on Cingulate Inc. future price: according to them, CING price has a max estimate of 62.00 USD and a min estimate of 8.00 USD. Watch CING chart and read a more detailed Cingulate Inc. stock forecast: see what analysts think of Cingulate Inc. and suggest that you do with its stocks.
CING reached its all-time high on Dec 8, 2021 with the price of 1,236.00 USD, and its all-time low was 1.80 USD and was reached on Aug 14, 2024. View more price dynamics on CING chart.
See other stocks reaching their highest and lowest prices.
CING stock is 5.69% volatile and has beta coefficient of 8.96. Track Cingulate Inc. stock price on the chart and check out the list of the most volatile stocks — is Cingulate Inc. there?
Today Cingulate Inc. has the market capitalization of ‪16.71 M‬, it has increased by 17.66% over the last week.
Yes, you can track Cingulate Inc. financials in yearly and quarterly reports right on TradingView.
Cingulate Inc. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
CING earnings for the last quarter are −1.82 USD per share, whereas the estimation was −1.38 USD resulting in a −32.36% surprise. The estimated earnings for the next quarter are −1.01 USD per share. See more details about Cingulate Inc. earnings.
Cingulate Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CING net income for the last quarter is ‪−6.13 M‬ USD, while the quarter before that showed ‪−3.23 M‬ USD of net income which accounts for −89.75% change. Track more Cingulate Inc. financial stats to get the full picture.
No, CING doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 13 employees. See our rating of the largest employees — is Cingulate Inc. on this list?
Like other stocks, CING shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cingulate Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cingulate Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cingulate Inc. stock shows the sell signal. See more of Cingulate Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.